Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin for acute idiopathic central serous chorioretinopathy
IRCT2012072810414N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rifampicin, sponsored by Guilan University of Medical Sciences. Started Jul 2012; status: completed.
02
Drugs
rifampicin
Beyond the preview
Go deeper on IRCT2012072810414N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012072810414N1.